At Medtronic Diabetes, our 20 plus year history vividly reflects our dedication and ongoing vision to develop an "artificial pancreas55".
In 1983, we pioneered the idea of continuous insulin delivery, introducing our first insulin pump in an effort to find a "better way" to deliver insulin for people with diabetes.
Since that time, Medtronic Diabetes has remained the market leader, earning a reputation for excellence in insulin pump therapy and continuous glucose monitoring.
· We were the first to introduce continuous glucose monitoring products to the market and the only to offer an FDA approved device for professionals.
· We are the only company working towards delivering the first artificial pancreas onto the market within the next few years.
· We are committed to refining our support services and tools to build our patients' trust and confidence.
We think you'll agree, our advanced insulin pump therapy, combined with our continuous glucose monitoring products delivers state-of-the-art diabetes management solutions to people with diabetes – not only today, but well into the future.